Drug distribution within the body is a complex process influenced by several factors, including perfusion rate, the rate at which the bloodstream transports drugs to tissue. This limitation becomes particularly significant when dealing with highly lipophilic drugs. In such cases, the rate at which the drug can move across membranes is crucial, and if the membrane is highly permeable to the drug, distribution becomes rate-limited by perfusion.
Perfusion rate-limited distribution relies on the speed of blood flow or tissue perfusion. Highly perfused tissues, meaning they receive a rich blood supply, can quickly reach equilibrium with lipophilic drugs. Equilibrium refers to the point at which the drug's concentration in the bloodstream equals its concentration in the tissue.
The extent of drug distribution within a specific tissue or organ depends on two main factors: the tissue size and the tissue/blood partition coefficient. The partition coefficient indicates how readily a drug partitions or distributes between the tissue and the blood.
Consider the example of thiopental, a lipophilic drug with a high tissue/blood partition coefficient, especially towards the brain and adipose tissue. When thiopental is injected intravenously, it rapidly diffuses into the brain, leading to a swift onset of action. However, the drug takes longer to distribute in adipose tissue, which is poorly perfused compared to other tissues.
As thiopental approaches equilibrium in adipose tissue, it diffuses out of the brain to maintain equilibrium between the brain and the blood. The drug accumulates in the adipose tissue due to its larger volume, and this redistribution of the drug to adipose tissue results in the rapid termination of its action. The drug is sequestered in the fat tissue, away from the active sites where it exerts its effects, rapidly stopping its pharmacological effects.
The interplay among perfusion rates, tissue size, and partition coefficients significantly influences the distribution of lipophilic drugs within the body. Understanding these dynamics is essential for predicting the onset and duration of drug effects and optimizing drug therapies for patients.
Do Capítulo 4:
Now Playing
Pharmacokinetics: Drug Distribution and Protein Binding
48 Visualizações
Pharmacokinetics: Drug Distribution and Protein Binding
89 Visualizações
Pharmacokinetics: Drug Distribution and Protein Binding
81 Visualizações
Pharmacokinetics: Drug Distribution and Protein Binding
109 Visualizações
Pharmacokinetics: Drug Distribution and Protein Binding
141 Visualizações
Pharmacokinetics: Drug Distribution and Protein Binding
56 Visualizações
Pharmacokinetics: Drug Distribution and Protein Binding
119 Visualizações
Pharmacokinetics: Drug Distribution and Protein Binding
49 Visualizações
Pharmacokinetics: Drug Distribution and Protein Binding
42 Visualizações
Pharmacokinetics: Drug Distribution and Protein Binding
74 Visualizações
Pharmacokinetics: Drug Distribution and Protein Binding
44 Visualizações
Pharmacokinetics: Drug Distribution and Protein Binding
77 Visualizações
Pharmacokinetics: Drug Distribution and Protein Binding
41 Visualizações
Pharmacokinetics: Drug Distribution and Protein Binding
28 Visualizações
Copyright © 2025 MyJoVE Corporation. Todos os direitos reservados